Search - tctmd.com

Displaying 141 - 160 of 175

Sort: Relevancy | Date

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

Presentation CTO 2014

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Presenter: Philippe Généreux

March 01, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

Presentation

Role of Drug Coated Balloons in Acute Coronary Syndrome

Presenter: Bruno Scheller

December 02, 2013

Presentation

Drug-Coated Balloons for Treatment of Coronary Artery Disease: Updated Recommendations from a Consensus Group

Presenter: Bruno Scheller

December 01, 2013

Presentation TCT 2013

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

Presenter: William Gray

October 31, 2013

Presentation TCT 2013

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

Presenter: Michael Conte

October 31, 2013

Presentation TCT 2013

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Presenter: Thomas Zeller

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Presenter: Ron Waksman

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Presenter: Christoph Naber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

Presenter: Bernardo Cortese

October 31, 2013

Presentation TCT 2013

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Presenter: Erwin Blessing

October 31, 2013

Presentation TCT 2013

Acute Coronary Syndromes Including STEMI: Is There a Need and a Role for Drug-Coated Balloons?

Presenter: Pieter Stella

October 31, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

Drug-eluting Balloon Bests Angioplasty for In-stent Restenosis

Jason Kahn

September 27, 2013

Advertisement

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Role of Drug Coated Balloons in Acute Coronary Syndrome

Drug-Coated Balloons for Treatment of Coronary Artery Disease: Updated Recommendations from a Consensus Group

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Acute Coronary Syndromes Including STEMI: Is There a Need and a Role for Drug-Coated Balloons?

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

Drug-eluting Balloon Bests Angioplasty for In-stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content